In short, as a multi-target drug, it activates the receptors of GLP-1, GIP, and GLP-2 to comprehensively regulate blood sugar, weight, and intestinal health, demonstrating its great potential in treating metabolic diseases such as obesity and type 2 diabetes
Our in-house team reviewed each provider across several key factors
Nasal spray loses 60-70% of the peptide and produces slower, less consistent results
This decline happens naturally with age, but obesity accelerates the process significantly
While both forms can be used as a supplement, ALCAR is often preferred due to its ability to cross the blood-brain barrier allowing it to interact with nerves in the brain, and also donate its acetyl molecule, a key step in neurotransmitter formation, required for healthy brain activity